4//SEC Filing
Mayer Arie 4
Accession 0001213900-26-001275
CIK 0001176309other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:20 PM ET
Size
6.8 KB
Accession
0001213900-26-001275
Insider Transaction Report
Form 4
Mayer Arie
Director
Transactions
- Award
Common Stock
2025-12-31+30,000→ 163,109 total - Award
Common Stock
2025-12-31+4,900→ 168,009 total
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs"). The RSUs will vest ratably in three annual tranches beginning January 1, 2027. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.
- [F2]Represents RSUs. The RSUs will vest in quarterly installments over a one-year period starting April 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeother
Related Parties
1- filerCIK 0001796583
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:20 PM ET
- Size
- 6.8 KB